# pathway_0172

[All questions and paired results](../README.md) · [Method](../METHOD.md) · [Source credits](../THIRD_PARTY_NOTICES.md)

**Task:** `pathway`  
**Author expected answer:** **A** — Cofactor biosynthesis

| Reviewer | Expected-answer support | Reasoning / lookup | Validity |
|---|---|---|---|
| GPT-6 Luna | supported | lookup-dependent | valid_review |
| Qwen3.8-Flash-Next-NVFP4 | supported | lookup-dependent | valid_review |

**Paired comparison:** key agree; reasoning agree. Agreement is not proof of correctness. These are separate AI judgments, with no forced consensus or changed key.

## Complete original question

```text
[Protein Sequence]
MTAAGFNSILCLRQLVRLNRRQYSAPAKSVLSGSQTNDQATPPPTSKSADKMRGWQLHNYGDIDELQLSEMLKIPQIRCSNECLVRIRATAVNPIDLAMLRGYGATVLNKMRCQPGDGIEFPLILGREFCGELVQTGMGVSLPLGSRVWGVVPLQATIGSHAEYVAVPSYCLAPAPKELDDYEAASVLYAGLTAWSGLYITGGLGGPCGATTASGGGAHKRVLVLGGSGGVGTLAIQILKSQKVQVLATCSENAIEMVRNLGADLVVDYNNPQAMEELCKYAPYDIVLDCAGQGGQKAAESKYDFRQYITFSSPLLANIDKQGLGVGALKNVFDLFQTNVRSVTQRGGLVKWGFFSPAPQGIQFLQKLVEQRKLMPLIDSSYGFSELPKAFEKMKSGHLRGKIVVKLREETGD

[Multiple Choices]
A. Cofactor biosynthesis
B. O-acetyl-L-homoserine from L-homoserine: step 1/1. .
C. dTTP biosynthesis. .
D. Pyrimidine metabolism
```

<details>
<summary>Original system instructions, verbatim</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Protein Pathway Prediction, which is to predict the primary metabolic or signaling pathway in which a given protein functions. Biological pathways are series of chemical reactions occurring within a cell that are essential for life. Based on the protein's amino acid sequence, you should identify the most relevant pathway from the given options.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## GPT-6 Luna

**Saved status:** `valid_review`.

### Expected-answer support: supported

> The supplied sequence exactly matches Drosophila melanogaster RTN4IP1. UniProt annotates this protein in cofactor biosynthesis, specifically ubiquinone biosynthesis, citing a 2024 study with experimental evidence attribution. This supports choice A; the annotation is protein-specific evidence, not a conclusion available from the sequence alone.

Citations as saved: [C1](#evidence-c1), [C5](#evidence-c5), [C6](#evidence-c6), [H3](#evidence-h3).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The sequence may suggest an enzyme and mitochondrial targeting, but those features do not establish its pathway or distinguish cofactor biosynthesis from the listed alternatives.


**Missing item-specific fact**

> The protein-specific identification and functional annotation linking RTN4IP1 to ubiquinone/cofactor biosynthesis, or equivalent experimental evidence, are absent from the input.


**Reason**

> Choosing A requires an item-specific functional fact or external identification. Recognizing the sequence or recalling its database annotation would be lookup or memorization, not reasoning from the supplied evidence.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> Among the choices, cofactor biosynthesis is the option consistent with the protein-specific ubiquinone-biosynthesis annotation; the other options name different pathways or a distinct metabolic step.


### Important caveats

- The reviewer-only evidence reports an exact sequence match to the current and historical UniProt records; those records were not provided to the evaluated model.
- The pathway annotation cites a study and carries an experimental evidence code, but the primary study was not independently reviewed here.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence may suggest an enzyme and mitochondrial targeting, but those features do not establish its pathway or distinguish cofactor biosynthesis from the listed alternatives.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The protein-specific identification and functional annotation linking RTN4IP1 to ubiquinone/cofactor biosynthesis, or equivalent experimental evidence, are absent from the input.",
    "reason": "Choosing A requires an item-specific functional fact or external identification. Recognizing the sequence or recalling its database annotation would be lookup or memorization, not reasoning from the supplied evidence."
  },
  "case_id": "pathway_0172",
  "expected_answer_check": {
    "evidence_ids": [
      "C1",
      "C5",
      "C6",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The supplied sequence exactly matches Drosophila melanogaster RTN4IP1. UniProt annotates this protein in cofactor biosynthesis, specifically ubiquinone biosynthesis, citing a 2024 study with experimental evidence attribution. This supports choice A; the annotation is protein-specific evidence, not a conclusion available from the sequence alone."
  },
  "important_caveats": [
    "The reviewer-only evidence reports an exact sequence match to the current and historical UniProt records; those records were not provided to the evaluated model.",
    "The pathway annotation cites a study and carries an experimental evidence code, but the primary study was not independently reviewed here."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Among the choices, cofactor biosynthesis is the option consistent with the protein-specific ubiquinone-biosynthesis annotation; the other options name different pathways or a distinct metabolic step."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "pathway_0172",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The supplied sequence exactly matches Drosophila melanogaster RTN4IP1. UniProt annotates this protein in cofactor biosynthesis, specifically ubiquinone biosynthesis, citing a 2024 study with experimental evidence attribution. This supports choice A; the annotation is protein-specific evidence, not a conclusion available from the sequence alone.",
    "evidence_ids": ["C1", "C5", "C6", "H3"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The sequence may suggest an enzyme and mitochondrial targeting, but those features do not establish its pathway or distinguish cofactor biosynthesis from the listed alternatives.",
    "missing_item_specific_fact": "The protein-specific identification and functional annotation linking RTN4IP1 to ubiquinone/cofactor biosynthesis, or equivalent experimental evidence, are absent from the input.",
    "reason": "Choosing A requires an item-specific functional fact or external identification. Recognizing the sequence or recalling its database annotation would be lookup or memorization, not reasoning from the supplied evidence."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Among the choices, cofactor biosynthesis is the option consistent with the protein-specific ubiquinone-biosynthesis annotation; the other options name different pathways or a distinct metabolic step."
  },
  "important_caveats": [
    "The reviewer-only evidence reports an exact sequence match to the current and historical UniProt records; those records were not provided to the evaluated model.",
    "The pathway annotation cites a study and carries an experimental evidence code, but the primary study was not independently reviewed here."
  ]
}
```

</details>

## Qwen3.8-Flash-Next-NVFP4

**Saved status:** `valid_review`.

### Expected-answer support: supported

> UniProt entry Q8IPZ3 (RT4I1_DROME, Drosophila melanogaster) explicitly annotates the pathway as 'Cofactor biosynthesis; ubiquinone biosynthesis' (evidence_id C5, H3) with experimental evidence code ECO:0000269 from PubMed:37884807 (Park et al., Nat. Chem. Biol. 2024). The 2024 paper experimentally demonstrates RTN4IP1/OPA10 is an oxidoreductase for coenzyme Q (ubiquinone) synthesis. The expected answer 'Cofactor biosynthesis' matches the UniProt pathway annotation exactly. Sequence match is confirmed (SHA-256 identical across current and historical entries).

Citations as saved: [C1](#evidence-c1), [C4](#evidence-c4), [C5](#evidence-c5), [C6](#evidence-c6), [H1](#evidence-h1), [H2](#evidence-h2), [H3](#evidence-h3).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> A weak argument exists: the sequence contains a Rossmann-fold-like FAD/NAD-binding motif (GGSGGVGT pattern around residues ~210-220), suggesting an FAD-dependent oxidoreductase. Ubiquinone biosynthesis involves several oxidoreductase steps, making 'cofactor biosynthesis' a plausible category for a quinone-related oxidoreductase. One could argue for eliminating B (homoserine O-acetylation is a transferase reaction, not an oxidoreductase), C and D (nucleotide metabolism enzymes have distinct structural architectures). However, this reasoning is speculative and does not uniquely identify ubiquinone biosynthesis among all oxidoreductase-containing pathways.


**Missing item-specific fact**

> The specific identification of RTN4IP1/OPA10 as a coenzyme Q biosynthesis oxidoreductase was established only in 2024 (Park et al., Nat. Chem. Biol. 20:221-233). The EC 1.6.5.2 assignment is by similarity (ECO:0000250|UniProtKB:Q8WWV3), not from the sequence itself. Without knowing this protein's specific identity or the 2024 experimental result, the sequence alone does not provide sufficient distinctive features to unambiguously assign it to 'cofactor biosynthesis' over other oxidoreductase-containing pathways. The UniProt pathway annotation was first published 2025-04-09.


**Reason**

> The correct pathway assignment (ubiquinone/cofactor biosynthesis) depends on protein-specific experimental knowledge from a 2024 publication. While the sequence shows FAD-binding motifs consistent with an oxidoreductase, this alone cannot distinguish 'cofactor biosynthesis' from other pathways involving oxidoreductases (e.g., pyrimidine metabolism includes dihydroorotate dehydrogenase, an FAD oxidoreductase). The answer requires recognizing this specific protein or knowing the 2024 experimental finding, making it lookup/memorization-dependent.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[
  "A"
]
```

> Option A is the only defensible answer given the UniProt annotation. Options B (homoserine O-acetylation, a transferase step), C (dTTP biosynthesis), and D (pyrimidine metabolism) are clearly incompatible with an FAD-dependent NAD(P)H:quinone oxidoreductase. The distractors are sufficiently distinct that a knowledgeable model recognizing oxidoreductase/quinone features would eliminate B, C, and D. No genuine ambiguity exists among the choices for a model with relevant training knowledge.


### Important caveats

- The RTN4IP1/OPA10 ubiquinone biosynthesis function was only experimentally established in 2024 (PubMed:37884807), making this a relatively recent annotation (first public date 2025-04-09).
- The EC number 1.6.5.2 is assigned by similarity to human Q8WWV3 (ECO:0000250), not directly demonstrated for the Drosophila protein from sequence alone.
- The pathway annotation is supported by experimental evidence (ECO:0000269) from the 2024 paper, not merely computational prediction.
- The sequence was first integrated into Swiss-Prot in April 2025; the original sequence dates to 2003. The pathway annotation is much newer than the sequence deposit.
- The reviewer-only evidence was absent from the evaluated model's input; the model must rely solely on the 413-aa sequence and the four pathway choices.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "A weak argument exists: the sequence contains a Rossmann-fold-like FAD/NAD-binding motif (GGSGGVGT pattern around residues ~210-220), suggesting an FAD-dependent oxidoreductase. Ubiquinone biosynthesis involves several oxidoreductase steps, making 'cofactor biosynthesis' a plausible category for a quinone-related oxidoreductase. One could argue for eliminating B (homoserine O-acetylation is a transferase reaction, not an oxidoreductase), C and D (nucleotide metabolism enzymes have distinct structural architectures). However, this reasoning is speculative and does not uniquely identify ubiquinone biosynthesis among all oxidoreductase-containing pathways.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The specific identification of RTN4IP1/OPA10 as a coenzyme Q biosynthesis oxidoreductase was established only in 2024 (Park et al., Nat. Chem. Biol. 20:221-233). The EC 1.6.5.2 assignment is by similarity (ECO:0000250|UniProtKB:Q8WWV3), not from the sequence itself. Without knowing this protein's specific identity or the 2024 experimental result, the sequence alone does not provide sufficient distinctive features to unambiguously assign it to 'cofactor biosynthesis' over other oxidoreductase-containing pathways. The UniProt pathway annotation was first published 2025-04-09.",
    "reason": "The correct pathway assignment (ubiquinone/cofactor biosynthesis) depends on protein-specific experimental knowledge from a 2024 publication. While the sequence shows FAD-binding motifs consistent with an oxidoreductase, this alone cannot distinguish 'cofactor biosynthesis' from other pathways involving oxidoreductases (e.g., pyrimidine metabolism includes dihydroorotate dehydrogenase, an FAD oxidoreductase). The answer requires recognizing this specific protein or knowing the 2024 experimental finding, making it lookup/memorization-dependent."
  },
  "case_id": "pathway_0172",
  "expected_answer_check": {
    "evidence_ids": [
      "C1",
      "C4",
      "C5",
      "C6",
      "H1",
      "H2",
      "H3"
    ],
    "judgment": "supported",
    "reason": "UniProt entry Q8IPZ3 (RT4I1_DROME, Drosophila melanogaster) explicitly annotates the pathway as 'Cofactor biosynthesis; ubiquinone biosynthesis' (evidence_id C5, H3) with experimental evidence code ECO:0000269 from PubMed:37884807 (Park et al., Nat. Chem. Biol. 2024). The 2024 paper experimentally demonstrates RTN4IP1/OPA10 is an oxidoreductase for coenzyme Q (ubiquinone) synthesis. The expected answer 'Cofactor biosynthesis' matches the UniProt pathway annotation exactly. Sequence match is confirmed (SHA-256 identical across current and historical entries)."
  },
  "important_caveats": [
    "The RTN4IP1/OPA10 ubiquinone biosynthesis function was only experimentally established in 2024 (PubMed:37884807), making this a relatively recent annotation (first public date 2025-04-09).",
    "The EC number 1.6.5.2 is assigned by similarity to human Q8WWV3 (ECO:0000250), not directly demonstrated for the Drosophila protein from sequence alone.",
    "The pathway annotation is supported by experimental evidence (ECO:0000269) from the 2024 paper, not merely computational prediction.",
    "The sequence was first integrated into Swiss-Prot in April 2025; the original sequence dates to 2003. The pathway annotation is much newer than the sequence deposit.",
    "The reviewer-only evidence was absent from the evaluated model's input; the model must rely solely on the 413-aa sequence and the four pathway choices."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [
      "A"
    ],
    "reason": "Option A is the only defensible answer given the UniProt annotation. Options B (homoserine O-acetylation, a transferase step), C (dTTP biosynthesis), and D (pyrimidine metabolism) are clearly incompatible with an FAD-dependent NAD(P)H:quinone oxidoreductase. The distractors are sufficiently distinct that a knowledgeable model recognizing oxidoreductase/quinone features would eliminate B, C, and D. No genuine ambiguity exists among the choices for a model with relevant training knowledge."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "pathway_0172",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "UniProt entry Q8IPZ3 (RT4I1_DROME, Drosophila melanogaster) explicitly annotates the pathway as 'Cofactor biosynthesis; ubiquinone biosynthesis' (evidence_id C5, H3) with experimental evidence code ECO:0000269 from PubMed:37884807 (Park et al., Nat. Chem. Biol. 2024). The 2024 paper experimentally demonstrates RTN4IP1/OPA10 is an oxidoreductase for coenzyme Q (ubiquinone) synthesis. The expected answer 'Cofactor biosynthesis' matches the UniProt pathway annotation exactly. Sequence match is confirmed (SHA-256 identical across current and historical entries).",
    "evidence_ids": ["C1", "C4", "C5", "C6", "H1", "H2", "H3"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "A weak argument exists: the sequence contains a Rossmann-fold-like FAD/NAD-binding motif (GGSGGVGT pattern around residues ~210-220), suggesting an FAD-dependent oxidoreductase. Ubiquinone biosynthesis involves several oxidoreductase steps, making 'cofactor biosynthesis' a plausible category for a quinone-related oxidoreductase. One could argue for eliminating B (homoserine O-acetylation is a transferase reaction, not an oxidoreductase), C and D (nucleotide metabolism enzymes have distinct structural architectures). However, this reasoning is speculative and does not uniquely identify ubiquinone biosynthesis among all oxidoreductase-containing pathways.",
    "missing_item_specific_fact": "The specific identification of RTN4IP1/OPA10 as a coenzyme Q biosynthesis oxidoreductase was established only in 2024 (Park et al., Nat. Chem. Biol. 20:221-233). The EC 1.6.5.2 assignment is by similarity (ECO:0000250|UniProtKB:Q8WWV3), not from the sequence itself. Without knowing this protein's specific identity or the 2024 experimental result, the sequence alone does not provide sufficient distinctive features to unambiguously assign it to 'cofactor biosynthesis' over other oxidoreductase-containing pathways. The UniProt pathway annotation was first published 2025-04-09.",
    "reason": "The correct pathway assignment (ubiquinone/cofactor biosynthesis) depends on protein-specific experimental knowledge from a 2024 publication. While the sequence shows FAD-binding motifs consistent with an oxidoreductase, this alone cannot distinguish 'cofactor biosynthesis' from other pathways involving oxidoreductases (e.g., pyrimidine metabolism includes dihydroorotate dehydrogenase, an FAD oxidoreductase). The answer requires recognizing this specific protein or knowing the 2024 experimental finding, making it lookup/memorization-dependent."
  },
  "question_ambiguity": {
    "multiple_defensible_options": ["A"],
    "reason": "Option A is the only defensible answer given the UniProt annotation. Options B (homoserine O-acetylation, a transferase step), C (dTTP biosynthesis), and D (pyrimidine metabolism) are clearly incompatible with an FAD-dependent NAD(P)H:quinone oxidoreductase. The distractors are sufficiently distinct that a knowledgeable model recognizing oxidoreductase/quinone features would eliminate B, C, and D. No genuine ambiguity exists among the choices for a model with relevant training knowledge."
  },
  "important_caveats": [
    "The RTN4IP1/OPA10 ubiquinone biosynthesis function was only experimentally established in 2024 (PubMed:37884807), making this a relatively recent annotation (first public date 2025-04-09).",
    "The EC number 1.6.5.2 is assigned by similarity to human Q8WWV3 (ECO:0000250), not directly demonstrated for the Drosophila protein from sequence alone.",
    "The pathway annotation is supported by experimental evidence (ECO:0000269) from the 2024 paper, not merely computational prediction.",
    "The sequence was first integrated into Swiss-Prot in April 2025; the original sequence dates to 2003. The pathway annotation is much newer than the sequence deposit.",
    "The reviewer-only evidence was absent from the evaluated model's input; the model must rely solely on the 413-aa sequence and the four pathway choices."
  ]
}
```

</details>

## Existing project source checks of Luna’s review

The notes below were prepared for specific claims in the Luna review. They are not independent validation of Qwen’s claims, expert adjudication, or replacement verdicts.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Reviewer-only source evidence

**Both reviewers received this source evidence separately from the original question. It was not available to the original evaluated model.** Source support and reasoning from the original sequence/choices are distinct assessments.

**Accession:** `Q8IPZ3` (recovered from dataset image-path metadata, not original question text).  
**Sequence applicability:** historical matched; current matched.  
**Historical cutoff:** 2026-05-07; archived entry version 178. Exact author snapshot unknown.

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.

### Evidence C1

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/Q8IPZ3.json)  
**Locator:** `/primaryAccession`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:32:18.576763+00:00.  

```json
"Q8IPZ3"
```

Source SHA-256: `e86069a21d68baee355342320a6ffe2ad016abdc8d4f641d55cad548579f2ea3`.

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/Q8IPZ3.json)  
**Locator:** `/proteinDescription`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:32:18.576763+00:00.  

```json
{"alternativeNames":[{"fullName":{"value":"Reticulon-4-interacting protein 1 homolog"},"shortNames":[{"evidences":[{"evidenceCode":"ECO:0000303","id":"37884807","source":"PubMed"}],"value":"dRtn4ip1"}]}],"flag":"Precursor","recommendedName":{"ecNumbers":[{"evidences":[{"evidenceCode":"ECO:0000250","id":"Q8WWV3","source":"UniProtKB"}],"value":"1.6.5.2"}],"fullName":{"evidences":[{"evidenceCode":"ECO:0000305"}],"value":"NAD(P)H oxidoreductase RTN4IP1, mitochondrial"}}}
```

Source SHA-256: `e86069a21d68baee355342320a6ffe2ad016abdc8d4f641d55cad548579f2ea3`.

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/Q8IPZ3.json)  
**Locator:** `/comments/3`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:32:18.576763+00:00.  

```json
{"commentType":"PATHWAY","texts":[{"evidences":[{"evidenceCode":"ECO:0000269","id":"37884807","source":"PubMed"}],"value":"Cofactor biosynthesis; ubiquinone biosynthesis"}]}
```

Source SHA-256: `e86069a21d68baee355342320a6ffe2ad016abdc8d4f641d55cad548579f2ea3`.

### Evidence C6

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/Q8IPZ3.json)  
**Locator:** `/references/4`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:32:18.576763+00:00.  

```json
{"citation":{"authors":["Park I.","Kim K.E.","Kim J.","Kim A.K.","Bae S.","Jung M.","Choi J.","Mishra P.K.","Kim T.M.","Kwak C.","Kang M.G.","Yoo C.M.","Mun J.Y.","Liu K.H.","Lee K.S.","Kim J.S.","Suh J.M.","Rhee H.W."],"citationCrossReferences":[{"database":"PubMed","id":"37884807"},{"database":"DOI","id":"10.1038/s41589-023-01452-w"}],"citationType":"journal article","firstPage":"221","id":"37884807","journal":"Nat. Chem. Biol.","lastPage":"233","publicationDate":"2024","title":"Mitochondrial matrix RTN4IP1/OPA10 is an oxidoreductase for coenzyme Q synthesis.","volume":"20"},"referenceNumber":5,"referencePositions":["FUNCTION","PATHWAY","DISRUPTION PHENOTYPE"]}
```

Source SHA-256: `e86069a21d68baee355342320a6ffe2ad016abdc8d4f641d55cad548579f2ea3`.

### Evidence H1

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/Q8IPZ3?format=txt&versions=178)  
**Locator:** `lines 1-17`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 178 / 1.  
**Retrieved:** 2026-11-02T04:32:22.972608+00:00.  

```text
ID   RT4I1_DROME             Reviewed;         413 AA.
AC   Q8IPZ3; Q8SZK7; Q9VQL4;
DT   09-APR-2025, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2003, sequence version 1.
DT   28-JAN-2026, entry version 178.
DE   RecName: Full=NAD(P)H oxidoreductase RTN4IP1, mitochondrial {ECO:0000305};
DE            EC=1.6.5.2 {ECO:0000250|UniProtKB:Q8WWV3};
DE   AltName: Full=Reticulon-4-interacting protein 1 homolog;
DE            Short=dRtn4ip1 {ECO:0000303|PubMed:37884807};
DE   Flags: Precursor;
GN   Name=Rtn4ip1 {ECO:0000312|FlyBase:FBgn0031500};
GN   ORFNames=CG17221 {ECO:0000312|FlyBase:FBgn0031500};
OS   Drosophila melanogaster (Fruit fly).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta; Pterygota;
OC   Neoptera; Endopterygota; Diptera; Brachycera; Muscomorpha; Ephydroidea;
OC   Drosophilidae; Drosophila; Sophophora.
OX   NCBI_TaxID=7227;
```

Source SHA-256: `c2044f60ca3ef3b11b8d9eda94d95aa716930f1e71581317ce51caed3192aef1`.

### Evidence H2

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/Q8IPZ3?format=txt&versions=178)  
**Locator:** `lines 85-93`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 178 / 1.  
**Retrieved:** 2026-11-02T04:32:22.972608+00:00.  

```text
RN   [5]
RP   FUNCTION, PATHWAY, AND DISRUPTION PHENOTYPE.
RX   PubMed=37884807; DOI=10.1038/s41589-023-01452-w;
RA   Park I., Kim K.E., Kim J., Kim A.K., Bae S., Jung M., Choi J., Mishra P.K.,
RA   Kim T.M., Kwak C., Kang M.G., Yoo C.M., Mun J.Y., Liu K.H., Lee K.S.,
RA   Kim J.S., Suh J.M., Rhee H.W.;
RT   "Mitochondrial matrix RTN4IP1/OPA10 is an oxidoreductase for coenzyme Q
RT   synthesis.";
RL   Nat. Chem. Biol. 20:221-233(2024).
```

Source SHA-256: `c2044f60ca3ef3b11b8d9eda94d95aa716930f1e71581317ce51caed3192aef1`.

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/Q8IPZ3?format=txt&versions=178)  
**Locator:** `lines 107-108`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 178 / 1.  
**Retrieved:** 2026-11-02T04:32:22.972608+00:00.  

```text
CC   -!- PATHWAY: Cofactor biosynthesis; ubiquinone biosynthesis.
CC       {ECO:0000269|PubMed:37884807}.
```

Source SHA-256: `c2044f60ca3ef3b11b8d9eda94d95aa716930f1e71581317ce51caed3192aef1`.

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/pathway.json), zero-based source row 172. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). UniProt and Gene Ontology credits are retained in [source notices](../THIRD_PARTY_NOTICES.md).
